Nutex Health Inc.: Form 10-K for the period ended Dec 31, 2017
Filed with the SEC on Apr 17, 2018 and accepted by EDGAR at Apr 17, 2018, 12:18 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 12 months2017-01-01 to 2017-12-31 | $30.5k | us-gaap:CostOfRevenue |
| Gross profit | 12 months2017-01-01 to 2017-12-31 | −$7.3k | us-gaap:GrossProfit |
| Operating income | 12 months2017-01-01 to 2017-12-31 | −$5.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2017-01-01 to 2017-12-31 | $367.4k | us-gaap:InterestExpense |
| Net income | 12 months2017-01-01 to 2017-12-31 | $582.1k | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2017-01-01 to 2017-12-31 | $0.01 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months2017-01-01 to 2017-12-31 | −$714.6k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2017-12-31 | $9.4k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-12-31 | $55.1k | us-gaap:AssetsCurrent |
| Total assets | At period end2017-12-31 | $3.3m | us-gaap:Assets |
| Current liabilities | At period end2017-12-31 | $959.8k | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2017-12-31 | $2.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001607062-18-000127. Last ingested by Listed: Nov 14, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.